Kolexia
Turpin Anthony Oncologie médicale
Turpin Anthony
Oncologie médicale
Hôpital Huriez
Lille, France
260 Activités
717 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Tumeurs du pancréas Métastase tumorale Tumeurs du foie Tumeurs des voies biliaires Tumeurs du côlon Carcinomes COVID-19

Collaborateurs

Voir plus
Neuzillet Cindy
Neuzillet Cindy
Institut Curie, Saint-Cloud, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France
Hautefeuille Vincent
Hautefeuille Vincent
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France
Bachet Jean Baptiste
Bachet Jean Baptiste
Hôpital Pitie Salpetriere, Paris, France

Industries

Voir plus
Servier
20 collaboration(s)
Dernière en 2023
B3TSI
6 collaboration(s)
Dernière en 2023
AstraZeneca
4 collaboration(s)
Dernière en 2022
Pierre Fabre
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
LAP-NET1: Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
Essai Clinique (NETRIS Pharma)   07 mars 2024
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
European journal of cancer (Oxford, England : 1990)   06 février 2024
CAPANCOVID-19: Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer
Essai Clinique (CHU Reims)   23 janvier 2024
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study: Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   03 janvier 2024
IMMUNO-BIL: Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy: a Randomized Non-comparative Two-arm Phase II Study
Essai Clinique (AstraZeneca)   03 janvier 2024
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
British journal of cancer   15 décembre 2023
Clinical and genomic characterization of pancreatic ductal adenocarcinoma patients with lung oligometastasis
ESMO Gastrointestinal Oncology   01 décembre 2023
Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case-control study.
Liver international : official journal of the International Association for the Study of the Liver   30 novembre 2023
SAFIR-ABC10: Molecular Targeted Maintenance Therapy Versus Standard of Care in Advanced Biliary Cancer: an International, Randomised, Controlled, Open-label, Platform Phase 3 Trial
Essai Clinique (Taiho Oncology, Inc.)   15 novembre 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   14 novembre 2023